Applied Optoelectronics to Present at Upcoming Investor Conferences

SUGAR LAND, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today announced the Company’s participation in the following investor conferences:

Event:	Needham Virtual Technology & Media Conference
Date:	Thursday, May 20th, 2021
Presentation Time:	3:00 p.m. Eastern time / 2:00 p.m. Central time
Presenter:	Stefan Murry, Chief Financial Officer and Chief Strategy Officer
Event:	Cowen Annual TMT Conference
Date:	Wednesday, June 2nd, 2021
Presentation Time:	4:30 p.m. Eastern time / 3:30 p.m. Central time
Presenter:	Stefan Murry, Chief Financial Officer and Chief Strategy Officer

Live audio webcasts of the presentations will be available on the investor relations section of the company’s website at investors.ao-inc.com.

About Applied Optoelectronics:

Applied Optoelectronics Inc. (AOI) is a leading developer and manufacturer of advanced optical products, including components, modules and equipment. AOI's products are the building blocks for broadband fiber access networks around the world, where they are used in the internet datacenter, CATV broadband, telecom and FTTH markets. AOI supplies optical networking lasers, components and equipment to tier-1 customers in all four of these markets. In addition to its corporate headquarters, wafer fab and advanced engineering and production facilities in Sugar Land, TX, AOI has engineering and manufacturing facilities in Taipei, Taiwan and Ningbo, China. For additional information, visit www.ao-inc.com. 

Investor Relations Contact:

The Blueshirt Group, Investor RelationsMonica Gould+1-212-871-3927                [email protected]

Lindsay Savarese+1-212-331-8417                [email protected]

Source: Applied Optoelectronics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
• Private Bancorp of America, Inc. Announces Strong Net Income and Earnings Per Share for First Quarter 2024
• Form 8.3 - DS Smith Plc.